Author name: Bob Carter

Articles, Blog posts

John D. Rockefeller Single-Handedly Ruins American Medicine

John D. Rockefeller Single-handedly Ruins American Medicine      By Robert Carter/December 23, 2024      By the early 1900s John D. Rockefeller had become the richest man in the world by taking over the American oil industry and making it his own personal monopoly. Unfortunately, the U.S. Supreme Court found him guilty of illegal business practices and racketeering.      He had to find himself another business venture that might be equally as profitable.      “Hey, how about drugs?” he decided.      Although the health of his own immediate family had always thrived on homeopathic remedies, he knew that these natural cures could not be patented. No money there.      But synthetic drugs could be patented, and there was BIG money there…if he could figure out how to corner that market, just as he had with his oil  monopoly.      He figured it out.      First, he invested hundreds of millions of dollars in the country’s most reputable medical schools – University of Chicago and Yale, to start with – provided they agreed to teach only allopathic, pharmaceutical based medicine. No more natural, nutrition based remedies would be spoken in those hallowed halls.      Then he invested in the German pharmaceutical giant I. G. Farben.      Yes…the same guys who from 1930-1938purged their company of every Jew, used 30,000 prisoners from Auschwitz as free, forced labor in one of their factories, and concocted the Zyklon B poisonous gas to help Hitler kill over a million prisoners in his gas chambers.      Next Rockefeller funded Abraham Flexner to tour the Rockefeller funded medical schools to  “evaluate” the new  treatments they were teaching. His 1906 Flexner Report helped persuade U.S. lawmakers to enact legislation that would license only those physicians trained in patented, chemical based pharmacology and surgery.      The AMA began a campaign of ridiculing any non-allopathic medical practices as “quackery” and soon our country’s natural remedy doctors were mostly out of business.       No more “Take two vitamin C and call me in the morning” from an American doctor.      Meanwhile the FDA had been evolving from the earlier Bureau of Chemistry, and it inherited from that agency the proviso that there was a “plausible deniability” for any legal culpability for harmful effects of the chemicals they monitored. That legal protection against pharmaceutical companies’ lawsuits remained in place until recently.      By 1916 Rockefeller had became the world’s first billionaire.      In 1930 Rockefeller expanded into psychiatry his influence over American medical practices when he established the Yale School of Psychiatry with a ten year grant totaling $1,000,000.      The 1930’s were already turning out to be a heyday for psychiatrics as they began conducting their experimentation with electroconvulsive shocks and trans-orbital lobotomies … all hidden from the public by using subjects from within their own psychiatric hospitals.      Kind of like the psychiatrists’ own little concentration camps.      In the 1930s Yale Medical School Professor C.E.A. Winslow worked to publicize and popularize America’s growing “mental hygiene movement,” and he helped position mental health treatment next to physical health treatment. Doing so helped usher in the age of massive public psychotropic prescriptions which began in the 1950’s after the brutality of psychiatrists covertly administering electroshock and lobotomy “treatments” had been publicly exposed.      Ironically, almost ninety-nine percent of all these psychotropic  pharmaceuticals contain petrochemicals, and so the Rockefeller family is still deriving its fortune from oil, even if today some of John D’s descendents do donate philanthropically to humanitarian non-profits.      However, we can still thank John D. alone for gifting us with what is now the medical mafia: Big Pharma, the FDA, and psychiatry.

Latest News

Big Pharma Push for FDA Approval of Psychedelic-based Antidepressants

Gold Rush Mentality Surrounds Big Pharma Push for FDA Approval of Psychedelic-based Antidepressants      By Robert Carter/December 8, 2024      Even some psychiatrists have acknowledged that the last fifty years of their medicating those diagnosed with schizophrenia – the umbrella term for most mental illnesses – has not beenparticularly successful. Big Pharma is on board with that assessment and is now investing millions in research into “breakthrough therapy” psychedelic-based medication to treat any number of mental disorders.      LSD, psilocybin and MDMA are all being tested in preparation for the first FDA approved clinical trials for these hallucinogens to be used to treat depression and anxiety as well as other mental “disorders.”Never mind that all three drugs have been classified as illegal Schedule 1 drugs that have a “high potential for abuse” and are without any “currently accepted medical use in treatment”.      Even the United States Drug Enforcement Administration has reported that the use of LSD in psychotherapy largely has been debunked, and “drug studies have confirmed that the powerful hallucinogenic effects of this drug can produce profound adverse reactions, such as acute panic reactions, psychotic crises, and “flashbacks”, especially in users ill-equipped to deal with such trauma.”      In the 1950s psychiatrists used LSD research to try to replicate the effects of mental illness, and their infamous MKUltra experiments used LSD covertly on often unsuspecting subjects to develop workable mind control techniques.      So why are so many dollars now pouring into what should be questionable psychedelic research?      Because the psychedelic therapeutics market has been valued at $2 billion in 2023 and it is expected to grow to $7 billion by 2031.      Nonprofits like the Multidisciplinary Association for Psychedelic Studies (MAPS) — now valued at $97 million in assets, all through donations — are cashing in on this psychedelics research gold rush. They have even donated over $20 million themselves to other organizations studying the use of psychedelics for therapeutic applications.      Just who are these new gold rush carpetbaggers?      MAPS therapists were videoed in 2022 spooning and pinning down a Phase 2 clinical trial participant in one study for the use of MDMA for PTSD therapy, as reported by New York Magazine. After that session one of the therapists sexually coerced the patient and the patient moved in with the therapists for the next two years.      MAPS lists Vicky Dulai as one of its three member Board of Directors. She “advises philanthropists and foundations about emerging opportunities in psychedelic research, treatment, and therapist training.” Vicky is their (very successful) fundraiser.      In May, 2021 Vicky was alleged in a civil lawsuit of exploiting multi-millionaire venture capitalist George Sarlo, then in his eighties, to extract more than $4 million from him while acting as his “psychedelic therapist” and feeding him ayahuasca, MDMA, and Ketamine.      The two of them had started a romantic relationship before he had had his first psychedelic  experience.      Sarlo gifted her $1.4 million for a house that she, her husband and children, had moved into. He “loaned” $190,000 to her husband for a business investment and he gave her a $65,000 Porsche.      Vicky used $30,000 of Sarlo’s philanthropic funds for private schooling for her children, received a $5150 monthly salary as director of his charitable foundation, and in just the first quarter of 2021 withdreaw more than $300,000 from Sarlo’s personal checking account to fly with her family and Sarlo to Hawaii on a private jet that itself cost $75,000.      The civil case against Vicky was settled out of court and no criminal charges were ever filed. She and Sarlo often participated together in psychedelic fundraising and networking events, and after Sarlo made a $1 million donation to MAPS, Vicky was given her seat on the board of directors.      That’s who these carpetbaggers are.       Back in 1998, a United Nations report estimated that the illegal synthetic drug market at that time, which included psychedelics, was $60 million.      Today’s unscrupulous opportunists like Vicky Dalai are doing their best to ensure this new, legal psychedelic drug market is not far behind.

Articles, Blog posts

LSD and Mini-ECT For Kids

LSD and Mini-ECT: Psychiatry Says They’re Just What Your Kid Needs      By Robert Carter/December 6, 2024      On October 30 th the Child Mind Institute held its annual On the Shoulders of Giants Symposium. The theme of the virtual event was promoted as “a celebration of scientific achievement in child and adolescent psychiatry” and two “breakthrough” treatments for childhood mental disorders were touted as next generation innovative therapies.      The two treatments?      Deep brain stimulation and an LSD derivative medication.      Just what your kid needs, eh?      Deep brain stimulation is a sort of street legal  variation of electroconvulsive shock. It’s used to fend off the legal restrictions looming on the horizon for banning the use of ECT’s horrific voltage being applied to youngsters. Four states have already passed legislation against its use on minors and more state legislatures will probably follow suit.      To treat a child with deep brain stimulation, a small electrode is surgically and permanently placed in the brain to deliver an electrical impulse that is supposed to regulate a child’s moods. The shocks are emitted twenty-four hours a day, seven days a week.      The FDA has only  approved deep brain  stimulation for such  physical disorders as  Parkinson’s Disease and dystonia, both chronic diseases of the brain. The National Institute of Health notes that “it is not  understood precisely how DBS affects the  dopaminergic networks within the brain” and that “DBS is not entirely without risk, and complications such as infection, hemorrhage, and even mortality have been noted.”      Nice, huh?      The other “breakthrough” treatment of the Child Mind Institute symposium is the proposal for an LSD derivative medication to treat child anxiety.      LSD was classified as an illegal Schedule 1 drug in the 1960s because it has a "high potential for abuse" and is without any "currently accepted medical use in treatment." In fact, in the 1950s psychiatrists used LSD research to try to replicate the effects of mental illness, and their infamous MKUltra  experiments used LSD on often unsuspecting subjects to help develop workable mind control techniques.      The United States Drug Enforcement Administration has reported that the use of LSD in psychotherapy largely has been debunked” and “drug studies have confirmed that the powerful hallucinogenic effects of this drug can produce profound adverse reactions, such as acute panic reactions, psychotic crises, and ‘flashbacks’ especially in users ill-equipped to deal with such trauma.”      Like young children.      Although the symposium literature lists these two treatments as  “breakthrough,” that term is actually only a designation used by the FDA – “breakthrough therapy” — to expedite the development and review of drugs that might demonstrate improvement over available therapy. It’s a fast track to clinical trials so that potentially more dangerous medications can be brought to market more quickly through clinical trials.     Go, Big Pharma. Their funding of seventy-five percent of the FDA’s pharmaceutical department budget will have been a small price to pay for the profits possible when these two “breakthrough” therapies are FDA approved for public consumption.          With approval, Big Pharma’s huge marketing budget can then be directed toward convincing you that a little LSD and a little electroshock really is just what your kid needs. (A thank you to Barbie Rivera of Hollywood Education and Literacy Project, Miami for alerting us about this in her recent newsletter).

Articles, Blog posts

Killing Vets Softly with a Psychiatric Solution

Killing Vets Softly with a Psychiatric Solution      By Robert Carter/November 20, 2025      U.S. Defense Secretary Lloyd Austin announced this week that American active duty military suicides are up again in 2023. The number of military who have  committed suicide has been a rising trend since 2011.  The Army and the Air Force had the largest rise in  suicides with the number of active duty troops killing themselves going from 331 to 363.      Austin said these numbers “urgently  demonstrate the need for the Department to redouble its work in the complex fields of suicide prevention and post-vention. There’s still much more work to do, and we won’t let up.” He added the Department of Defense is “moving urgently” to put changes in place by increasing “mental health assistance” to troops.      Part of Austin’s program focuses on education of troops on gun safety, locks, and storage. That seems an odd target as active duty troops probably have more access to firearms than any other population in the country, and they also have more training in their use and their safety than anyone else.      The problem is in the urge to commit suicide, not in the means available to do it. The increase in what Austin calls “mental health assistance” to active duty troops will undoubtedly include easier access to counselors, therapists and psychiatrists as well as the tools that are included with that therapy.      Psychotropic medication, of course, is one of the most frequently used “tools.”      According to a 2013 Military Times report, antidepressants and anticonvulsants were the most commonly prescribed psychotropic medications for service members with mental health conditions. Records show that from 2001 to 2009 alone, the Defense Logistics Agency, which manages the entire Department of Defense supply chain, spent $1.1 billion on common psychiatric drugs and pain medications.      Austin’s current proposal to increase “mental health assistance” for the military will undoubtedly boost that drug budget well beyond that $1.1 billion.      Can it be that the military does not know of the studies that show that taking psychotropic medication increases one’s risk of committing suicide?      Research shows that Xanax, for instance, the benzodiazepine drug most prescribed for anxiety, doubles the risk of suicide for those taking it. One study has shown that after taking Xanax, a person has a 54% increase in suicide thoughts or attempts at suicide.      Could it be that the billion dollar military expenditure on psychotropic drugs is itself the cause of the continuing increase in active duty military suicides?       Now there’s a chance that even more psychotropic drugs will be prescribed and further increase the number of suicides…the very deaths they are supposed to prevent.      “Strumming my pain with his fingers,      killing me softly with his song.”

Articles, Blog posts

How to Sue a Shrink

How to Sue a Shrink      By Robert Carter/November 3, 2024      We are not advocating here the willy-nilly suing of a psychiatrist. In this increasingly litigious society there are already far too many frivolous lawsuits.      However, if one suspects a psychiatrist has strayed from professional, legal or ethical standards of practice, one can report the individual to the state licensing board. There are also a number of websites with standard report forms to submit which list the specifics of the suspected transgression. CCHR and PsychSearch are two such reputable websites, and they immediately forward these reports to the appropriate authorities.      One can, of course, also sue a psychiatrist for malpractice, if the facts warrant it.      State laws do vary, but generally speaking, any time a medical professional’s actions no longer adhere to a standard of care used by the majority of responsible health care providers, a psychiatrist may be subject to a lawsuit as well as to discipline by a state medical board.      Here are the two most common categories of legal transgressions by a psychiatrist which show a level of negligence that would support a malpractice suit.      More practically, this list can also be used to assess for non-standard practices that should be reported to medical authorities, regardless if there are grounds for a successful lawsuit or not.      General unethical conduct: Having a sexual relationship with a patient Verbal or physical abuse Planting false memories in a patient. Trading medical treatment for other goods or services Failing to keep a patient’s medical information confidentialMedical malpractice:Failure to adequately deliver and have a signed Informed Consent procedure Not carrying out a thorough neurological evaluation when the condition calls for it Failure to adequately test and monitor a patient’s response to medication Any other significant p rescription medication errors Misdiagnosing a patient’s condition Failing to adequately monitor a patient, especially one with a risk of suicide Improper record keeping, including falsification of medical records      Should you sue a shrink?      Yes…if there are obvious grounds for it. Apparently, there often are.      The website PsychSearch offers a list of psychiatrists – state by state and country by country – who have either been disciplined by their medical boards or have been successfully prosecuted for medical and ethical “sins.”      It is not a short list.      In fact, according to a 2020 article in Clinical Psychiatry News, “Forty-one percent of U.S. psychiatrists have been sued for malpractice at least once.”      That’s close to a fifty/fifty chance you have that the psychiatrist you see has a practice…or that he has a malpractice.

Latest News

Chairman of Arkansas State Medical Board Hit with Medical Fraud

Psychiatrist and Chairman of Arkansas State Medical Board Hit with Medical Fraud Criminal Charges and over 100 Lawsuits      By Robert Carter/November 3, 2024      The trial of psychiatrist Brian Wyatt has recently been postponed to next spring because of his attorneys’ full schedule. Wyatt was arrested last year for two criminal charges of “large scale medical fraud” for billing Medicaid for appointments he never had with patients.      In early 2023 a confidential informant had reported Hyatt to the Arkansas medical authorities as director of Northwest Medical’s Behavioral Health in Springdale for “significant growth in the unit and likewise in the claims and billings submitted to Medicaid, Medicare, and private insurance” under his time at the helm. Hyatt was arrested eight months later for two counts of large scale Medicaid fraud.      Since then more than 100 of Hyatt’s ex-patients have filed lawsuits against him for “unlawfully coercing, abusing and holding patients against their will” within the Springdale, Arkansas, Behavioral Unit in order to receive greater reimbursement from Medicare between 2018 and 2022.      One patient was charged over $14,000 for a five day stay at the unit, for example, but he never once saw Dr. Hyatt himself. In fact, Hyatt is reported to have issued orders to his staff to mark out his name on his patients’ wristbands so they would not know his name.      William VanWhy, one of the patients filing a lawsuit against Hyatt through the Odom Law Firm, reported that “I stayed there for about five days under Dr. Hyatt’s care. I have never seen him in my life. I’ve never met him, even though I was under his care. I asked to leave every day for the last three days and they wouldn’t let me leave.”      VanWhy’s insurance was then billed for two in-person visits during his stay, per reports, with his total charges in the tens of thousands of dollars.      Matt Lindsay of the Odom Law Firm also reported that many of his clients were chemically restrained, but never got any help in the unit. “Beyond not getting help, they got much worse, and they are still every day living with the effects of what they went through at that facility,” Lindsay said.      The initial informant about Hyatt had also reported that the psychiatrist was only on the floor for a few minutes each day and that he had no contact with patients.       Hyatt has pleaded not guilty to the two Medicaid criminal fraud charges.      One can’t help but wonder how much the spectacular – if utterly fraudulent – growth of the Springdale Behavioral Health Unit under his tenure was a factor in Hyatt achieving the position of Chairman of the Arkansas State Medical Board.      Certainly the psychiatrist did not arrive in that position because of his extraordinary and selfless care for his patients.

Latest News

Research Shows No Gene Causes Schizophrenia

Thirty Years of Research Show No Gene Causes Schizophrenia Robert Carter/August 27, 2024     After reviewing almost thirty years of research by The Human Genome Project, prominent biological psychiatrist E. Fuller Torrey has concluded that schizophrenia “does not appear to be a genetic disorder.”      The Human Genome Project began in 1990 with the goal of determining all of the fundamental units that make up human DNA, and the human genome has approximately 3.1 billion of these base units. In August 2023 the final report was published by this publicly funded, multi-billion dollar project.      The National Institute of Mental Health spent $8 billion in its own thirty year attempt to find a biological cause of various mental “illnesses” through the data collected in the Human Genome project. Schizophrenia was specifically targeted.      After Dr. Torrey recently reviewed all of this research, though, he wrote that “not a single gene has been found that can be causally linked to schizophrenia and the research has produced no improvements in treatments.”      The Human Genome Project is the largest collaborative biological research project ever done and its extensive research spans thirty years. If no gene has been found by the project which is shown to be a cause of schizophrenia, there is little likelihood one ever will be.       Psychiatry’s theory of a “chemical imbalance” in the brain being the cause of a mental disorder is further debunked by this research, and Big Pharma’s subsequent launch of serotonin associated antidepressants to treat people’s “chemical imbalances” is shown to be, at best, foolhardy.      Antidepressants sales in 2024 are estimated to be $17 billion. Quite a profit for Big Pharma.      Not “foolhardy” for them.

Latest News

Pfizer/GSK Takes Another Big Financial Hit for Its Pharmaceutical Greed

Pfizer/GSK Takes Another Big Financial Hit for Its Pharmaceutical Greed      By Robert Carter/October 18, 2024      Big Pharma giant Pfizer/GSK agreed out of court this month to pay more than $2.2 billion to settle pending lawsuits against its product Zantac after the FDA pulled it from the market for being a possible carcinogen.      The culprit ingredient in Zantac, a heartburn medication, is ranitidine, a synthetic chemical concocted in one of Glaxo’s research laboratories in England in 1977. A “reverse pharmacology” approach was used to determine if modulating an existing biomolecule might have a therapeutic effect. This research technique might violate the “it’s not nice to mess with Mother Nature” axiom, but nevertheless the product was introduced to the market in 1981. By 1987 it had become the world’s biggest selling prescription drug.      It was not until almost thirty years later in 2019 that widespread reports — confirmed by an extensive Taiwanese study in 2022 showed evidence of ranitidine as potentially carcinogenic because of an inherent instability of the ranitidine molecule. The FDA ordered pharmaceutical manufacturers of products like Zantac which contained ranitidine to pull them from the market.      As the original patents for ranitidine had expired over the years, other pharmaceutical companies had entered competition for this lucrative market. Last month the French pharmaceutical giant Sanofi paid $100 million in out of court settlements to plaintiffs suing the company for its ranitidine product. This month Pfizer/GSK followed suit and settled their own lawsuits out of court for $2.2 billion.      When the initial clinical trials of a new pharmaceutical product are rushed to be completed — either as they are conducted or as their findings are written up for the FDA — the safety of a product for public consumption can be at risk. When that happens, the public themselves begin participating – unknowingly – in what is then virtually an extended clinical trial for the product.      It took thirty years for enough broad evidence of cancer in ailing consumers caused by the Pfizer drug to surface and cause the FDA to ban the product.      That evidence also arrived in the form of 80,000 lawsuits from Pfizer/GSK’s ranitidine product Zantac. It should be noted that Pfizer/GSK did not publicly accept any responsibility for a “faulty” produce, but said that they were only settling these lawsuits to mitigate future legal expenses for their company.      The FDA, which approved the drug, is not funded exclusively by the U.S. government, of course. Forty-five percent of its annual budget comes from the fees Big Pharma pays to apply for approval for a new drug, and seventy-five percent of the FDA’s antidepressant approval department comes from Big Pharma fees.      Zantac’s annual sales grew to more than $1 billion within five years of its release to the public. That’s quite a return on the comparatively modest approval fee paid to the FDA.      Even the $2.2 billion just paid to settle these lawsuits is a small price to pay for those decades of profit from Zantac.      The far heftier price was paid by those hundreds of thousands of people suing these Big Pharma firms because of the cancer they had suffered from ranitidine

Articles, Blog posts

“Chemical Imbalance” and “Major Depressive Disorder”: Pure Orwellian 1984 Newspeak

“Chemical Imbalance” and “Major Depressive Disorder”: Pure Orwellian 1984 Newspeak      By Robert Carter/October 17, 2024      “…but if thought corrupts language, language can also corrupt thought.”      George Orwell, author of 1984 and Animal Farm, wrote those words in his 1946 essay “Politics and the English Language.” Although his essay was a post-WWII warning about the manipulative use of language for political purposes, his analysis of the deterioration of a person’s ability to think clearly when using language that has been purposefully corrupted is pertinent to Big Pharma’s marketing of psychiatric medication.      Orwell argued that the deceitful use of language that is then placed into public use easily leads the public to accept ideas without examining them. If language has been corrupted by distorting the meaning of words, a new false vocabulary tends to prevent the public from thinking clearly enough to be able to reject the false terms in it.      Consequently, the purveyors of corrupted language can easily become the “authority.” The insider knowledge they claim through their distorted vocabulary — because it’s a false representation of reality — inhibits public access to actuality.      Corrupt and deceitful terms not only distort the language. They also distort the truth.      This insidious corruption of public thought is all the more dangerous because it is so subtle. In his novel 1984 Orwell called this technique of governmental brainwashing “Newspeak.”      It is the marketing tool used by Big Pharma and psychiatry today.      Take the term “chemical imbalance.” It has so fully entered the public consciousness – despite no laboratory test ever having given any proof that such a thing exists – that millions of Americans now freely ingest antidepressants based on this bogus theory that there’s a bodily chemical imbalance that can somehow be re-balanced by taking a psychotropic drug.      The American government doles out millions of dollars in funding for mental health initiatives based on the groundless idea of “chemical impbalance.” Last month alone, the Biden Administration gave grants of $68.5 million for behavioral health education, training and community programs, based on their acceptance of “chemical imbalance” as the cause of an already bogus psychiatric diagnosis for disorders such as Major Depressive Disorder (MDD).      Major Depressive Disorder is one more corruption of language by psychiatry which bends its definition away from truth, and that term has now become a popularized psychiatric buzz word. By labeling someone with MDD, antidepressants can then be prescribed…antidepressants that are dangerous enough to warrant the most severe of FDA black box warnings.      Like many other “disorders,” MDD was adopted by the American Psychiatric Association for inclusion in their 1980 edition of their Diagnostic and Statistical Manual of Mental Disorders. That “diagnosis” – which, when called that, is made to sound like a valid medical term, but it is not — is only based on individual’s own reported experiences, and their behavior as reported by relatives or friends, along with a list of manifested symptoms. There is no laboratory test for this “disorder.”      However, Big Pharma was able to reap $18.5 billion in antidepressant sales in 2023 because of this manipulation of language that has convinced people that antidepressants are unequivocally good for them…even though 54.7 percent of Xanax users have attempted suicide or had suicidal thoughts.      Both of these terms – chemical imbalance and major mental disorder — have entered the public vocabulary courtesy of the $1 billion per month marketing expenditures of Big Pharma in America alone (2022 figure). These two misleading terms – as well as many others from the DSM – have corrupted the public’s ability to think clearly about mental illness. And therefore about the truth.      That’s a form of brainwashing.      This corruption of language has unfortunately prevented too many public from seeing that this Big Pharma emperor has no clothes on.

Latest News

Biden’s White House: Victim of Big Pharma Propaganda

Biden’s White House: Victim of Big Pharma Propaganda      By Robert Carter/September 25, 2024      This month President Biden signed the bill to ease access for mental health treatments to 175 million Americans with private health insurance. This addendum to the Mental Health Parity Act will make it easier for those people to bill their insurance for mental health help, but it will also significantly increase the flow of dollars into Big Pharma’s antidepressant manufacturers.      Biden announced this Big Pharma windfall by stating that it ensures that “mental health coverage will be covered at the same level as other health care for Americans. There is no reason that breaking your arm should be treated differently than having a mental health condition.”      His parroting of the Big Pharma myth of the “chemical imbalance” theory of biological causes for mental disorders shows the extent to which Big Pharma’s mental health propaganda has penetrated American culture.      That’s not surprising. Last year alone, 2023, Big Pharma spent almost $400 million lobbying congress to support pharmaceuticals and other health products.      In fact, Biden himself is listed on opensectrets.org as the top benefactor ever of Big Pharma’s extravagant donations to congressmen. Biden has received over $9 million in donations from Big Pharma.      In fact, one of the initial sponsors for the original Mental Health Parity Act in 1996, Senator Domenici, himself received over $150,000 in Big Pharma donations during his congressional career.      It is true that mental health issues and substance abuse seem to be on the rise in America, and the passage of this bill will offer more help to those needing it in today’s stressful world. But is pharmaceutical “help” truly a benefit to those suffering if it is based on a debunked “chemical imbalance theory?      Even the former Director of the National Institute of Mental Health is dubious of the value of this kind of mental health treatment.      In 2017 he stated, “I spent 13 years at NIMH really pushing on the neuroscience and genetics of mental disorders, and when I look back on that I realize that while I think I succeeded at getting lots of really cool papers published by cool scientists at fairly large costs — I think $20 billion — I don’t think we moved the needle in reducing suicide, reducing hospitalizations, improving recovery for the tens of millions of people who have mental illness.”      Joanna Moncrieff, a consulting psychiatrist at the North London National Health Service and Professor of Psychiatry at University College London, has said, “It is always difficult to prove a negative, but I think we can safely say that after a vast amount of research conducted over several decades, there is no convincing evidence that depression is caused by serotonin abnormalities, particularly by lower levels or reduced activity of serotonin. The popularity of the ‘chemical imbalance’ theory of depression has coincided with a huge increase in the use of antidepressants. Many people take antidepressants because they have been led to believe their depression has a biochemical cause, but this new research suggests this belief is not grounded in evidence.”      “This belief,” however, is grounded in huge profits for Big Pharma, which has spent untold billions convincing the public and politicians of the validity of this bogus theory.

Scroll to Top